FDAFDA · Food and drugs·Recall number D-0767-2022
Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06
Published April 6, 2022 · Recall initiated: March 8, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Brand
- MECLIZINE HYDROCHLORIDE
- Manufacturer
- Jubilant Cadista Pharmaceuticals, Inc.
- Distributor
- Product was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio.
- UPC
- 0359746121068
- Lot
- Lot # 22P0036, Exp 12/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.